<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03251742</url>
  </required_header>
  <id_info>
    <org_study_id>Fontan0615</org_study_id>
    <nct_id>NCT03251742</nct_id>
  </id_info>
  <brief_title>Feasibility and Efficacy of Portable Non-invasive Negative Pressure Ventilation in Fontan Patients</brief_title>
  <acronym>FONTAN-CMR</acronym>
  <official_title>Feasibility and Efficacy Of Negative Pressure Ventilation in Fontan populatioN: Cardiovascular Flow Assessment by Magnetic Resonance Imaging</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Health Network, Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hayek Medical</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Health Network, Toronto</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The human heart has 4 chambers: 2 collecting chambers (atria) and 2 pumping chambers
      (ventricles) to allow blood flow within two distinct circuits: &quot;pulmonary&quot; and &quot;systemic&quot;.
      The pulmonary circuit directs the blood to the lungs to receive oxygen and the systemic
      circuit delivers oxygen-rich blood throughout the body. In children born with a single
      ventricle, blood from these two circuits mixes within the heart resulting in lower oxygen
      levels in the blood delivered to the body (cyanosis).

      The Fontan procedure is a palliative surgery which bypasses the need for a ventricle to
      deliver blood to the lungs, as blood from the body flows passively to the lungs by a man-made
      connection (whereby two large body veins [cavae] are sewn to the pulmonary arteries), thereby
      preventing mixing of blood through restoration of two distinct circuits without mixing of
      blood. Although the Fontan operation effectively eliminates cyanosis and enables survival
      into adulthood, increased systemic venous pressure is an unavoidable systemic complication
      and low cardiac output (CO) is pervasive finding.

      Despite excellent pediatric surgical results, the risk of late complications and death
      dramatically increases in the decades following Fontan surgery. A chronically low CO state
      secondary to decreased forward flow of blood to the lungs can result in end-organ dysfunction
      and shortened life expectancy. Short of heart transplantation, deemed suitable only for a
      minority of patients, effective therapies for low CO are largely absent. The investigators
      aim to investigate a novel, non-invasive, ambulatory therapy which can augment CO.
      Specifically, external suction is applied intermittently to the chest wall, much like a
      vacuum, to increase CO, called negative pressure ventilation (NPV) using a CuirassÂ®
      ventilator (Hayek Medical). Although used in patients with lung disease, the investigators'
      proposal is to evaluate this novel, portable, ventilation system would be the first study of
      its kind in adults with congenital heart disease, specifically those with a Fontan
      palliation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 17, 2017</start_date>
  <completion_date type="Anticipated">August 30, 2018</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>This is a cross-sectional study designed to evaluate the immediate impact of negative pressure ventilation (NPV) in an ambulatory Fontan population using cardiovascular magnetic resonance imaging (CMR) for assessment of cardiovascular flows.</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy of the NPV on cardiac output</measure>
    <time_frame>6-8 months</time_frame>
    <description>Cardiac output will be measured in L/min/m2 using phase contrast MRI. Flow measurements will be made at baseline and with application of the device.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Efficacy of the NPV on organ perfusion</measure>
    <time_frame>6-8 months</time_frame>
    <description>Multi organ perfusion will be measured in L/min/m2 using phase contrast MRI. Flow measurements will be made at baseline and with application of the device.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Tolerability and safety of negative pressure ventilation.</measure>
    <time_frame>6-8 months</time_frame>
    <description>Assessed by participant questionnaire rating tolerance, safety, overall satisfaction with the device.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Fontan Physiology</condition>
  <arm_group>
    <arm_group_label>Fontan patient population</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy volunteers</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hayek RTX ventilator</intervention_name>
    <description>Negative pressure ventilation in Fontan patients.</description>
    <arm_group_label>Fontan patient population</arm_group_label>
    <arm_group_label>Healthy volunteers</arm_group_label>
    <other_name>Cuirass</other_name>
    <other_name>Negative pressure ventilation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Fontan patients age &gt; 13 years.

        Exclusion Criteria:

          -  unable to complete MRI (pacemaker/defibrillator/retained wires, pregnancy,
             claustrophobia);

          -  evidence of Fontan failure (requiring ongoing medical / device therapy) protein-losing
             enteropathy, intracardiac thrombus, anatomical obstruction to the Fontan circuit;

          -  patent Fontan fenestration;

          -  oxygen saturation &lt; 90%;

          -  ongoing arrhythmia;

          -  ejection fraction &lt; 50% on echocardiography or CMR;

          -  moderate or severe valve insufficiency on echocardiography or CMR;

          -  Obesity (BMI &gt;35);

          -  severe obstructive sleep apnea (AHI&gt;20);

          -  chronic obstructive lung disease (FEV1/FVC&lt;60%);

          -  severe chest wall deformities (scoliosis, kyphosis, kyphoscoliosis);

          -  acute or chronic kidney disease (eGFR&lt;60)

          -  unable to provide informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>13 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rachel Wald, MD, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Toronto General Hospital/University Health Network</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pradeepkumar Charla, MD, MS</last_name>
    <role>Study Director</role>
    <affiliation>Toronto General Hospital/University Health Network</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pradeepkumar Charla, MD, MS</last_name>
    <phone>4163404800</phone>
    <phone_ext>4497</phone_ext>
    <email>pradeepkumar.charla@uhn.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alana Lee, RN</last_name>
    <phone>4163404800</phone>
    <phone_ext>6539</phone_ext>
    <email>Alana.lee@uhn.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Toronto General Hospital/University of Toronto.</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G2N2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pradeepkumar Charla, MD/MS</last_name>
      <phone>4163404800</phone>
      <phone_ext>4497</phone_ext>
      <email>pradeepkumar.charla@uhn.ca</email>
    </contact>
    <contact_backup>
      <last_name>Alana Lee, RN</last_name>
      <phone>4163404800</phone>
      <phone_ext>6539</phone_ext>
      <email>alana.lee@uhn.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Rachel Wald, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pradeepkumar Charla, MD/MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Erwin Oechslin, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>John Granton, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Shi-Joon Yoo, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 4, 2017</study_first_submitted>
  <study_first_submitted_qc>August 15, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 16, 2017</study_first_posted>
  <last_update_submitted>November 17, 2017</last_update_submitted>
  <last_update_submitted_qc>November 17, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Health Network, Toronto</investigator_affiliation>
    <investigator_full_name>Pradeepkumar Charla</investigator_full_name>
    <investigator_title>Clinical Fellow</investigator_title>
  </responsible_party>
  <keyword>Fontan operation</keyword>
  <keyword>Negative pressure ventilation</keyword>
  <keyword>MRI</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

